Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung ...

Inhaled Corticosteroid Treatment in COPD: Boon or Bane? Are inhaled corticosteroids overused in patients with COPD? This review explores the benefits and risks of inhaled corticosteroid-based ...

While people can develop chronic obstructive pulmonary disease (COPD) no matter where they live, the condition is more common — and has worse outcomes — in some regions of the country.

It’s often measured by a test called the 6-minute walking test. One of the key features of COPD is systemic inflammation. A blood test that checks for certain markers of inflammation may be helpful.

Dupilumab vs placebo was linked to improved health-related quality of life and respiratory symptoms in patients with COPD and T2 inflammation.

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.

The combo of arthritis and COPD increases by 41% the risk of death from any cause People with arthritis and COPD also have a 29% increased risk of heart-related death MONDAY, March 17, 2025 ...

Global health projections indicate that COPD will affect approximately 600 million individuals by 2050, with diabetic patients facing a 35% higher risk of developing the condition. This ...